Top Markets
Coin of the day
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
株式のランク #32762
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
株価
$2.26
時価総額
$9.19M
変化(1日)
1.76%
変化(1年)
-22.92%
JP
取引 PhoenixBio Co., Ltd. (6190)

カテゴリー

PhoenixBio Co., Ltd.(6190)の配当利回りの履歴
PhoenixBio Co., Ltd.(銘柄コード: 6190)の配当利回り(TTM)は2026時点で0です。
過去5年間の平均配当利回り: 0.00%
PhoenixBio Co., Ltd.(6190)の2026から2026までの配当利回りの履歴
各年末時点の配当利回り(TTM)
配当利回り 変化
提供された日付のデータは十分ではありません。
類似企業または競合他社の配当利回り(TTM)